Concepedia

Christopher E. Heise

CE

42

Publications

5.4K

Citations

28

H-Index

1998

Active since

Affiliations

Neurocrine Biosciences (United States)(Current)

University of Virginia

Neuroscience Institute

University of Toronto

Shanghai Zhangjiang Laboratory

Christopher E. Heise is an author at Neurocrine Biosciences (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1998–2024

42

Publications

42

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Volker Brinkmann, Michael D. Davis, Christopher E. Heise et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text

, , +16

Characterization of the Human Cysteinyl Leukotriene 2 Receptor

Christopher E. Heise, Brian F. O’Dowd, David J. Figueroa et al. · Journal of Biological Chemistry · 2000 · 660 citations · Full text

, , +7

Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability

Benjamin Lauffer, Robert Mintzer, Rina Fong et al. · Journal of Biological Chemistry · 2013 · 400 citations · Full text

Optimized arylomycins are a new class of Gram-negative antibiotics

Peter A. Smith, Michael F. T. Koehler, Hany S. Girgis et al. · Nature · 2018 · 348 citations

, , +6

Characterization of a Novel Sphingosine 1-Phosphate Receptor, Edg-8

Dong‐Soon Im, Christopher E. Heise, Nicolas Ancellin et al. · Journal of Biological Chemistry · 2000 · 325 citations · Full text

Rows per page

1–5 of 42